Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 3—March 2002
Research

Molecular Epidemiology of Adenovirus Type 7 in the United States, 1966–20001

Dean D. Erdman*Comments to Author , Wanhong Xu*, Susan I. Gerber†, Gregory C. Gray‡, David Schnurr§, Adriana E. Kajon¶, and Larry J. Anderson*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Chicago Department of Public Health, Chicago, Illinois, USA; ‡Naval Health Research Center, San Diego, California, USA; §California Department of Health Services, Berkeley, California, USA; ¶Lovelace Respiratory Research Institute, Albuquerque, New Mexico, USA;

Main Article

Figure

Restriction profiles of representative human adenovirus (Ad) genome types Ad7b (1), Ad7d2 (2), and Ad7h (3) after digestion with selected enzymes, BamHI, Sma I, BstEII, BglII, and BcII. DNA markers II (λ HindIII) and III (λ HindIII/EcoRI).

Figure. Restriction profiles of representative human adenovirus (Ad) genome types Ad7b (1), Ad7d2 (2), and Ad7h (3) after digestion with selected enzymes, BamHI, Sma I, BstEII, BglII, and BcII. DNA markers II (λ HindIII) and III (λ HindIII/EcoRI).

Main Article

1These data were presented in part at the International Conference on Emerging Infectious Diseases, July 16-19, 2000, Atlanta, GA.

Page created: July 14, 2010
Page updated: July 14, 2010
Page reviewed: July 14, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external